HOPE Therapeutics and NRx Pharmaceuticals to acquire a minority stake in Cohen and Associates.

HOPE Therapeutics, a clinical care delivery organization, and NRx Pharmaceuticals, biopharmaceutical company, agreed to acquire a minority stake in Cohen and Associates, a Psychiatry clinic. Financial terms were not disclosed. "We are delighted to welcome Rebecca and her team to the HOPE family. Her extensive experience with neuroplastic therapies, combined with compassionate patient care exemplify our culture of bringing HOPE to life," Jonathan Javitt and Matthew Duffy, HOPE Therapeutics Co-CEOs.